SCHEMBL28032734

SCHEMBL28032734

CCOc1nccc(Br)c1C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
LRRK2 Q5S007 1/20 0.45
ALDH1A1 P00352 3/20 0.38
GRM5 P41594 1/20 0.37
NQO1 P15559 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
RPS6KA5 O75582 1/20 0.34
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
S1PR1 P21453 1/20 0.33
HCRTR2 O43614 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
DHODH Q02127 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27978326 0.80 SMN1; SMN2 (0.56) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5
SCHEMBL18686677 0.79 SMN1; SMN2 (0.37) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5
SCHEMBL16231386 0.79 HPGD (0.50) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5
SCHEMBL4080885 0.78 HPGD (0.63) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5
SCHEMBL16213742 0.77 SMN1; SMN2 (0.53) HPGDSMN1; SMN2LRRK2ALDH1A1KMT2A
SCHEMBL22247426 0.77 CNR2 (0.39) HPGDSMN1; SMN2
SCHEMBL14117235 0.76 HPGD (0.47) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5
SCHEMBL14853027 0.76 HPGD (0.67) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5
SCHEMBL25411688 0.74 LRRK2 (0.46) HPGDSMN1; SMN2LRRK2ALDH1A1
SCHEMBL28718097 0.74 HPGD (0.55) HPGDSMN1; SMN2LRRK2ALDH1A1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102791713-B Imidazo [1,2-A ] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases JANSSEN PHARMACEUTICA N.V. (BE) 2016-02-03 CN disclosed
CN-102596961-B Imidazo [1,2-b] pyridazine derivatives and the purposes as PDE10 inhibitor thereof JANSSEN PHARMACEUTICA N.V. (BE) 2015-12-02 CN disclosed